2015 Annual Meeting | Obesity and Neurological Disorders
| 01:00 PM - 01:05 PM |
Introduction
|
|
| 01:00 PM - 05:00 PM | Abstract |
001 - Cognitive Dysfunction in Obese Individuals With or Without Metabolic Risk Factors
Alaa Abu Saleh |
| 01:00 PM - 05:00 PM | Abstract |
002 - CSF Characteristics in Patients with High Frisén Papilledema Grades from the IIHTT
John Pula, MD, FAAN |
| 01:00 PM - 05:00 PM | Abstract |
004 - Body Mass Index and Stroke Subtype in a Young Adult Stroke Population
Jina M. Youn, MD, MS |
| 01:00 PM - 05:00 PM | Abstract |
005 - Eating Behaviour and Metabolic Changes across the Spectrum of Motor Neuron Disease and Frontotemporal Dementia.
Rebekah M. Ahmed, MD |
| 01:00 PM - 05:00 PM | Abstract |
006 - Effects of Intervention on Optical Imaging of Papilledema in the Idiopathic Intracranial Hypertension Treatment Trial
Mark J. Kupersmith, MD, FAAN |
| 01:00 PM - 05:00 PM | Abstract |
007 - Obesity and Overweight are Highly Prevalent in Pediatric Secondary Pseudotumor Cerebri Syndrome
Grace Paley, MD, PhD |
| 01:00 PM - 05:00 PM | Abstract |
008 - Body Weight and Survival after Stroke: Exploring the “Obesity Paradox” in the Framingham Study
Hugo Javier Aparicio, MD, MPH |
| 01:00 PM - 05:00 PM | Abstract |
009 - Metabolic Syndrome and Ischemic Stroke Risk by Sex: Meta-analysis
Michelle P. Lin, CRC |
| 01:00 PM - 05:00 PM | Abstract |
011 - Overdiagnosis of Idiopathic Intracranial Hypertension (IIH)
Adeniyi Fisayo, MD |
| 01:00 PM - 05:00 PM | Abstract |
012 - Adiponectin deficiency induced cognitive impairment in aging mice through reductions in insulin sensitivity and AMPK activation
Roy C. NG |
| 01:00 PM - 05:00 PM | Abstract |
013 - The effect of obesity on severity of cognitive impairment and neuropsychiatric symptoms in MCI subjects
Ashley H. Sanderlin |
| 01:05 PM - 01:30 PM |
Obesity and Idiopathic Intracranial Hypertension
Michael Wall, MD, FAAN |
|
| 01:30 PM - 01:35 PM |
Effects of Intervention on Optical Imaging of Papilledema in the Idiopathic Intracranial Hypertension Treatment Trial
Mark J. Kupersmith, MD, FAAN |
|
| 01:35 PM - 01:40 PM |
Obesity and Overweight are Highly Prevalent in Pediatric Secondary Pseudotumor Cerebri Syndrome
Grace Paley, MD, PhD |
|
| 01:40 PM - 01:50 PM |
Audience Q&A
|
|
| 01:50 PM - 02:15 PM |
Obesity and Stroke
Bruce I. Ovbiagele, MD, MSc, FAAN |
|
| 02:15 PM - 02:20 PM |
Body Weight and Survival after Stroke: Exploring the “Obesity Paradox” in the Framingham Study
Hugo Javier Aparicio, MD, MPH |
|
| 02:20 PM - 02:25 PM |
Metabolic Syndrome and Ischemic Stroke Risk by Sex: Meta-analysis
Michelle P. Lin, CRC |
|
| 02:35 PM - 02:45 PM |
Break
|
|
| 02:45 PM - 03:10 PM |
Obesity and Sleep: Beyond Obstructive Sleep Apnea
Hrayr P. Attarian, MD, FAAN |
|
| 03:10 PM - 03:15 PM |
Effect of “Snoring Alone” and “Snoring Plus Phenomenon” on Cardiovascular Diseases, or Fatal or Nonfatal Stroke
Yousef Mohammad, MD |
|
| 03:15 PM - 03:20 PM |
Overdiagnosis of Idiopathic Intracranial Hypertension (IIH)
Adeniyi Fisayo, MD |
|
| 03:20 PM - 03:30 PM |
Audience Q&A
|
|
| 03:30 PM - 03:55 PM |
Adipocytokines and Migraine
B. L. Peterlin, DO |
|
| 03:55 PM - 04:20 PM |
Obesity and Neurocognitive Decline
Hussein Yassine, MD |
|
| 04:20 PM - 04:25 PM |
Adiponectin Deficiency Induced Cognitive Impairment in Aging Mice through Reductions in Insulin Sensitivity and AMPK Activation
Roy C. NG |
|
| 04:25 PM - 04:30 PM |
The Effect of Obesity on Severity of Cognitive Impairment and Neuropsychiatric Symptoms in MCI Subjects
Ashley H. Sanderlin |
|
| 04:30 PM - 04:35 PM |
Audience Q&A
|
|
| 04:35 PM - 05:00 PM |
Guided Poster Rounds
|
| Deborah I. Friedman, MD, MPH, FAAN | Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Satsuma. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . The institution of Dr. Friedman has received research support from Spinal CSF Leak Foundation. Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Treasurer, Board of Directors with Southern Headache Society that is relevant to AAN interests or activities. |
| Janet C. Rucker, MD | Dr. Rucker has nothing to disclose. |
| Mark J. Kupersmith, MD, FAAN | Dr. Kupersmith has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal firms. Dr. Kupersmith has stock in SafeTherapeutics m,LLC. The institution of Dr. Kupersmith has received research support from NEI, NYEEI FDN, Shulman Family NAION fund. Dr. Kupersmith has received intellectual property interests from a discovery or technology relating to health care. |
| Michelle P. Lin, CRC | Dr. Lin has nothing to disclose. |
| Grace Paley, MD, PhD | No disclosure on file |
| Ashley H. Sanderlin | No disclosure on file |
| Adeniyi Fisayo, MD | Dr. Fisayo has nothing to disclose. |
| Hugo Javier Aparicio, MD, MPH | Dr. Aparicio has received research support from 好色先生. Dr. Aparicio has received research support from Alzheimer's Association. Dr. Aparicio has received research support from National Institutes of Health. Dr. Aparicio has received personal compensation in the range of $10,000-$49,999 for serving as a expert panelist for the Memory & Healthy Aging Program with Cedars-Sinai. |
| Roy C. NG | No disclosure on file |
| Michael Wall, MD, FAAN | No disclosure on file |
| Bruce I. Ovbiagele, MD, MSc, FAAN | Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities. |
| Hrayr P. Attarian, MD, FAAN | Dr. Attarian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview. Dr. Attarian has received publishing royalties from a publication relating to health care. |
| B. L. Peterlin, DO | Dr. Peterlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for J&J. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. |
| Hussein Yassine, MD | Hussein Yassine, MD has nothing to disclose. |
| Yousef Mohammad, MD | No disclosure on file |
| Jorge C. Kattah, MD, FAAN | Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm. |
| Beau B. Bruce, MD, FAAN | Dr. Bruce has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Bayer. |
| Michael McDermott | No disclosure on file |
| Alexa Beiser | Alexa Beiser has nothing to disclose. |
| Philip A. Wolf, MD, FAAN | No disclosure on file |
| Sudha Seshadri, MD, FAAN | Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association. |
| Nancy J. Newman, MD, FAAN | Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophth. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Newman has received research support from GenSight. The institution of Dr. Newman has received research support from Santhera. The institution of Dr. Newman has received research support from NINDS/NIH. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. |
| Muhammad F. Suri, MD | Dr. Suri has nothing to disclose. |
| Valerie Biousse, MD | Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care. |
| Carlos S. Kase, MD, FAHA, FAAN | Dr. Kase has nothing to disclose. |
| No disclosure on file | |
| Joni M. Clark, MD | No disclosure on file |
| Jina M. Youn, MD, MS | Dr. Youn has nothing to disclose. |
| Ahmed A. Malik, MD | No disclosure on file |
| Hamza I. Maqsood, MD | Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. |
| Amy T. Towfighi, MD | Dr. Towfighi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law firms. The institution of Dr. Towfighi has received research support from NIH. |
| Gustavo Saposnik, MD | Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada. |
| Omar Saeed, MD | Dr. Saeed has nothing to disclose. |
| Luis J. Mejico, MD, FAAN | No disclosure on file |
| Grant Liu, MD, FAAN | Dr. Liu has received publishing royalties from a publication relating to health care. |
| Alaa Abu Saleh | No disclosure on file |
| Jayandra Himali | Jayandra Himali has nothing to disclose. |
| Matthew C. Kiernan, MBBS, PhD, FRACP | The institution of Prof. Kiernan has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for British Medical Journal Publishers (UK). |
| Thandar Aung, MD | Dr. Aung has nothing to disclose. |
| John Pula, MD, FAAN | Dr. Pula has nothing to disclose. |
| Glenda Halliday | No disclosure on file |
| Radi S. Shahien, MD | Dr. Shahien has nothing to disclose. |
| Rebekah M. Ahmed, MD | Dr. Ahmed has nothing to disclose. |
| Andrea Bozoki, MD, FAAN | Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creative Biopeptides. Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. The institution of Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AviadoBio. The institution of Dr. Bozoki has received research support from Cognition Therapeutics. The institution of Dr. Bozoki has received research support from EIP Pharma. The institution of Dr. Bozoki has received research support from Transposon Therapeutics. The institution of Dr. Bozoki has received research support from Alector . |
| Claire A. Sheldon, MD, PhD | No disclosure on file |
| Ahmad Alsibai, MD | Dr. Alsibai has nothing to disclose. |